Altered Developmental Expression of the Astrocyte-Secreted Factors Hevin and SPARC in the Fragile X Mouse Model

Area of Science:

• Neuroscience
• Developmental Biology
• Cell Biology

Background:

• Astrocyte dysfunction is implicated in neurodevelopmental disorders like Fragile X Syndrome (FXS).
• FXS results from a deficiency in fragile X mental retardation protein (FMRP), affecting synaptic development.
• Hevin and SPARC are astrocyte-derived factors crucial for excitatory synapse development.

Purpose of the Study:

• To investigate altered expression of astrocyte-derived factors hevin and SPARC in a mouse model of FXS.
• To determine if FMRP deficiency impacts hevin and SPARC levels in developing brain regions affected by FXS.

Main Methods:

• Analyzed hevin and SPARC expression in wild-type (WT) and Fmr1 knock-out (KO) mice.
• Collected samples from developing cortex and hippocampus at various postnatal days (P7, P14, P21).
• Utilized quantitative methods to compare protein levels between genotypes and brain regions.

Main Results:

• Hevin and SPARC expression patterns were altered in Fmr1 KO mice compared to WT in a region-specific manner.
• Cortical hevin showed a transient increase at P14 in KO mice; SPARC levels decreased modestly at P7 and P14.
• Hippocampal hevin was lower in P7 KO mice, normalized by P14, and surpassed WT levels by P21.

Conclusions:

• Aberrant astrocyte signaling occurs in FXS.
• Altered expression of hevin and SPARC likely contributes to abnormal synaptic development in FXS.
• These findings highlight potential therapeutic targets for FXS by modulating astrocyte-brain region specific signaling.